Henrike Salie

Hamburg, HH, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Extended longitudinal validation of serum procalcitonin as a biomarker for fibrolamellar hepatocellular carcinoma.

Extended longitudinal validation of serum procalcitonin as a biomarker for fibrolamellar hepatocellular carcinoma.

Journal: Journal of hepatology
Published: April 13, 2026

Circulating extracellular vesicles carrying PD-1, PD-L1 and CTLA-4 inform resistance to anti-PD-L1-based therapy in HCC.

Circulating extracellular vesicles carrying PD-1, PD-L1 and CTLA-4 inform resistance to anti-PD-L1-based therapy in HCC.

Journal: Gut
Published: November 21, 2025

TGF-β1 and TGF-β2 family members differentially modulate tumor initiation and invasiveness of primary liver cancer in a MMP14-dependent manner.

TGF-β1 and TGF-β2 family members differentially modulate tumor initiation and invasiveness of primary liver cancer in a MMP14-dependent manner.

Journal: Carcinogenesis
Published: October 24, 2025

Characteristic immune cell interactions in livers of children with acute hepatitis revealed by spatial single-cell analysis identify a possible postacute sequel of COVID-19.

Characteristic immune cell interactions in livers of children with acute hepatitis revealed by spatial single-cell analysis identify a possible postacute sequel of COVID-19.

Journal: Gut
Published: September 12, 2024

Anti-PD-1 cancer immunotherapy induces central nervous system immune-related adverse events by microglia activation.

Anti-PD-1 cancer immunotherapy induces central nervous system immune-related adverse events by microglia activation.

Journal: Science translational medicine
Published: June 12, 2024

Spatial single-cell profiling and neighbourhood analysis reveal the determinants of immune architecture connected to checkpoint inhibitor therapy outcome in hepatocellular carcinoma.

Spatial single-cell profiling and neighbourhood analysis reveal the determinants of immune architecture connected to checkpoint inhibitor therapy outcome in hepatocellular carcinoma.

Journal: Gut
Published: May 13, 2024

Evolutionary and immune microenvironment dynamics during neoadjuvant treatment of oesophagael adenocarcinoma.

Evolutionary and immune microenvironment dynamics during neoadjuvant treatment of oesophagael adenocarcinoma.

Journal: Research square
Published: April 24, 2023

Targeting TGFβ-activated kinase-1 activation in microglia reduces CAR T immune effector cell-associated neurotoxicity syndrome.

Targeting TGFβ-activated kinase-1 activation in microglia reduces CAR T immune effector cell-associated neurotoxicity syndrome.

Journal: Nature cancer
Published: April 18, 2023

Evolutionary and immune microenvironment dynamics during neoadjuvant treatment of esophageal adenocarcinoma.

Evolutionary and immune microenvironment dynamics during neoadjuvant treatment of esophageal adenocarcinoma.

Journal: Nature cancer
Published: March 26, 2023

SARS-CoV-2 vaccination can elicit a CD8 T-cell dominant hepatitis.

SARS-CoV-2 vaccination can elicit a CD8 T-cell dominant hepatitis.

Journal: Journal of hepatology
Published: January 18, 2022

In-Depth Molecular Characterization of Neovascular Membranes Suggests a Role for Hyalocyte-to-Myofibroblast Transdifferentiation in Proliferative Diabetic Retinopathy.

In-Depth Molecular Characterization of Neovascular Membranes Suggests a Role for Hyalocyte-to-Myofibroblast Transdifferentiation in Proliferative Diabetic Retinopathy.

Journal: Frontiers in immunology
Published: August 13, 2021

T-cell exhaustion and residency dynamics inform clinical outcomes in hepatocellular carcinoma.

T-cell exhaustion and residency dynamics inform clinical outcomes in hepatocellular carcinoma.

Journal: Journal of hepatology
Published: August 07, 2021
Showing 1-12 of 16

Last Updated: 09/26/2026